Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Odero

Showing results (31-40 of 74) with videos related to

Pageof 8
Sort By:
Genes, Chromosomes & Cancer|March 6, 2003
t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemiaJosé L Vizmanos, María J Larráyoz, Idoya Lahortiga, et al.
Oncology Reports|October 5, 2007
Multicolor interphase cytogenetics for the study of plasma cell dyscrasiasBorja Sáez, José I Martín-Subero, María D Odero, et al.
British Journal of Haematology|August 1, 1997
Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myelomaM J Calasanz, J C Cigudosa, M D Odero, et al.
Cancer Genetics and Cytogenetics|December 1, 1994
Cytogenetic data in 41 patients with multiple myeloma. Karyotype and other clinical parametersJ C Cigudosa, M J Calasanz, M D Odero, et al.
Journal of Biomedical Nanotechnology|August 28, 2015
Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid LeukemiaA Estella-Hermoso de Mendoza, R Castello-Cros, E Imbuluzqueta, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|April 10, 2017
The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cellsMiren Maicas, Iria Vázquez, Rafael Alis, et al.
Haematologica|March 7, 2008
In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemiaKim De Keersmaecker, Idoya Lahortiga, Nicole Mentens, et al.
Blood|February 17, 2005
Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32)Kim De Keersmaecker, Carlos Graux, Maria D Odero, et al.
Cancer Genetics and Cytogenetics|August 30, 2006
Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analysesBorja Sáez, José I Martín-Subero, Cristina Largo, et al.
Cancer Genetics and Cytogenetics|August 30, 2008
A new dic(7;12)(p12.21;p12.2) chromosome aberration in a case of acute myeloid leukemiaCinzia Tapinassi, Elvira Gerbino, Omar Malazzi, et al.
Pageof 8

Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Genes, Chromosomes & Cancer|March 6, 2003
t(10;16)(q22;p13) and MORF-CREBBP fusion is a recurrent event in acute myeloid leukemiaJosé L Vizmanos, María J Larráyoz, Idoya Lahortiga, et al.
Oncology Reports|October 5, 2007
Multicolor interphase cytogenetics for the study of plasma cell dyscrasiasBorja Sáez, José I Martín-Subero, María D Odero, et al.
British Journal of Haematology|August 1, 1997
Hypodiploidy and 22q11 rearrangements at diagnosis are associated with poor prognosis in patients with multiple myelomaM J Calasanz, J C Cigudosa, M D Odero, et al.
Cancer Genetics and Cytogenetics|December 1, 1994
Cytogenetic data in 41 patients with multiple myeloma. Karyotype and other clinical parametersJ C Cigudosa, M J Calasanz, M D Odero, et al.
Journal of Biomedical Nanotechnology|August 28, 2015
Lipid Nanosystems Enhance the Bioavailability and the Therapeutic Efficacy of FTY720 in Acute Myeloid LeukemiaA Estella-Hermoso de Mendoza, R Castello-Cros, E Imbuluzqueta, et al.
Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|April 10, 2017
The MDS and EVI1 complex locus (MECOM) isoforms regulate their own transcription and have different roles in the transformation of hematopoietic stem and progenitor cellsMiren Maicas, Iria Vázquez, Rafael Alis, et al.
Haematologica|March 7, 2008
In vitro validation of gamma-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemiaKim De Keersmaecker, Idoya Lahortiga, Nicole Mentens, et al.
Blood|February 17, 2005
Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32)Kim De Keersmaecker, Carlos Graux, Maria D Odero, et al.
Cancer Genetics and Cytogenetics|August 30, 2006
Identification of recurrent chromosomal breakpoints in multiple myeloma with complex karyotypes by combined G-banding, spectral karyotyping, and fluorescence in situ hybridization analysesBorja Sáez, José I Martín-Subero, Cristina Largo, et al.
Cancer Genetics and Cytogenetics|August 30, 2008
A new dic(7;12)(p12.21;p12.2) chromosome aberration in a case of acute myeloid leukemiaCinzia Tapinassi, Elvira Gerbino, Omar Malazzi, et al.
Pageof 8